|
1
|
Trowsdale J and Betz AG: Mother's little
helpers: Mechanisms of maternal-fetal tolerance. Nat Immunol.
7:241–246. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tafuri A, Alferink J, Möller P, Hämmerling
GJ and Arnold B: T cell awareness of paternal alloantigens during
pregnancy. Science. 270:630–633. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hogarth PJ: Immunological aspects of
foeto-maternal relations in lower vertebrates. J Reprod Fertil
Suppl. 3(Suppl 3): S15–S27. 1968.
|
|
4
|
Kaufmann P, Huppertz B and Frank HG: The
fibrinoids of the human placenta: Origin, composition and
functional relevance. Ann Anat. 178:485–501. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiong YH, Yuan Z and He L: Effects of
estrogen on CD4(+) CD25(+) regulatory T cell in peripheral blood
during pregnancy. Asian Pac J Trop Med. 6:748–752. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Terness P, Bauer TM, Röse L, Dufter C,
Watzlik A, Simon H and Opelz G: Inhibition of allogeneic T cell
proliferation by indoleamine 2,3-dioxygenase-expressing dendritic
cells: Mediation of suppression by tryptophan metabolites. J Exp
Med. 196:447–457. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mellor AL, Baban B, Chandler P, Marshall
B, Jhaver K, Hansen A, Koni PA, Iwashima M and Munn DH: Cutting
edge: Induced indoleamine 2,3 dioxygenase expression in dendritic
cell subsets suppresses T cell clonal expansion. J Immunol.
171:1652–1655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kudo Y, Boyd CA, Spyropoulou I, Redman CW,
Takikawa O, Katsuki T, Hara T, Ohama K and Sargent IL: Indoleamine
2,3-dioxygenase: Distribution and function in the developing human
placenta. J Reprod Immunol. 61:87–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Curti A, Trabanelli S, Salvestrini V,
Baccarani M and Lemoli RM: The role of indoleamine 2,3-dioxygenase
in the induction of immune tolerance: Focus on hematology. Blood.
113:2394–2401. 2009. View Article : Google Scholar
|
|
10
|
Ligam P, Manuelpillai U, Wallace EM and
Walker D: Localisation of indoleamine 2,3-dioxygenase and
kynurenine hydroxylase in the human placenta and decidua:
Implications for role of the kynurenine pathway in pregnancy.
Placenta. 26:498–504. 2006. View Article : Google Scholar
|
|
11
|
Liu W, Huang Y, Huang G, Zhou C, Zeng X,
Zhao S, Wu L, Zhou H, Wu Q and Dai L: Relationship of SOCS3 and
TGF-β with IDO expression in early pregnancy chorionic villi and
decidua. Exp Ther Med. 14:4817–4824. 2017.PubMed/NCBI
|
|
12
|
Fallarino F, Grohmann U, Vacca C, Bianchi
R, Orabona C, Spreca A, Fioretti MC and Puccetti P: T cell
apoptosis by trypto-phan catabolism. Cell Death Differ.
9:1069–1077. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Frumento G, Rotondo R, Tonetti M, Damonte
G, Benatti U and Ferrara GB: Tryptophan-derived catabolites are
responsible for inhibition of T and natural killer cell
proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med.
196:459–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hönig A, Rieger L, Kapp M, Sütterlin M,
Dietl J and Kämmerer U: Indoleamine 2,3-dioxygenase (IDO)
expression in invasive extravillous trophoblast supports role of
the enzyme for materno-fetal tolerance. J Reprod Immunol. 61:79–86.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang G, Zeng Y, Liang P, Zhou C, Zhao S,
Huang X, Wu L and He X: Indoleamine 2,3-dioxygenase (IDO)
downregulates the cell surface expression of the CD4 molecule. Int
J Mol Sci. 13:10863–10879. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Biernacka A, Dobazewski M and
Frangogiannis NG: TGF-β signaling in fibrosis. Growth Factor.
29:196–202. 2011. View Article : Google Scholar
|
|
17
|
Pallotta MT, Orabona C, Volpi C, Vacca C,
Belladonna ML, Bianchi R, Servillo G, Brunacci C, Calvitti M,
Bicciato S, et al: Indoleamine 2,3-dioxygenase is a signaling
protein in long-term tolerance by dendritic cells. Nat Immunol.
12:870–878. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
ESHRE Guideline Group on RPL; Bender Atik
R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, Nelen
W, Peramo B, Quenby S, et al: ESHRE guideline: Recurrent pregnancy
loss. Hum Reprod Open. 2018:hoy0042018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kudo Y: The role of placental indoleamine
2,3-dioxygenase in human pregnancy. Obstet Gynecol Sci. 56:209–216.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mei J, Li MQ, Ding D, Li DJ, Jin LP, Hu WG
and Zhu XY: Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival
and invasiveness of endometrial stromal cells via the activation of
JNK signaling pathway. Int J Clin Exp Pathol. 6:431–444.
2013.PubMed/NCBI
|
|
21
|
Honig A, Rieger L, Dietl J and Kämmerer U:
Mechanisms regulating the expression of indoleamine 2,3-dioxygenase
during decidualization of human endometrium. Hum Reprod.
19:2683–2684. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu WH, Lu CZ, Huang YM, Link H and Xiao
BG: A putative mechanism on remission of multiple sclerosis during
pregnancy: Estrogen-induced indoleamine 2,3-dioxygenase by
dendritic cells. Mult Scler. 13:33–40. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Troisi R, Potischman N, Johnson CN,
Roberts JM, Lykins D, Harger G, Markovic N, Siiteri P and Hoover
RN: Estrogen and androgen concentrations are not lower in the
umbilical cord serum of pre-eclamptic pregnancies. Cancer Epidemiol
Biomarkers Prev. 12(11 Pt 1): 1268–1270. 2003.PubMed/NCBI
|
|
24
|
Matalka KZ: The effect of estradiol, but
not progesterone, on the production of cytokines in stimulated
whole blood, is concentration-dependent. Neuro Endocrinol Lett.
24:185–191. 2003.PubMed/NCBI
|
|
25
|
Xuan YH, Choi YL, Shin YK, Ahn GH, Kim KH,
Kim WJ, Lee HC and Kim SH: Expression of TGF-beta signaling
proteins in normal placenta and gestational trophoblastic disease.
Histol Histopathol. 22:227–234. 2007.
|
|
26
|
Jones RL, Stoikos C, Findlay JK and
Salamonsen LA: TGF-beta superfamily expression and actions in the
endometrium and placenta. Reproduction. 132:217–232. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stevenson S, Nelson LD, Sharpe DT and
Thornton MJ: 17beta-estradiol regulates the secretion of TGF-beta
by cultured human dermal fibroblasts. J Biomater Sci Polym Ed.
19:1097–1109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lecanda J, Parekh TV, Gama P, Lin K,
Liarski V, Uretsky S, Mittal K and Gold LI: Transforming growth
factor-beta, estrogen, and progesterone converge on the regulation
of p27Kip1 in the normal and malignant endometrium. Cancer Res.
67:1007–1018. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ito L, Hanyu A, Wayama M, Goto N, Katsuno
Y, Kawasaki S, Nakajima Y, Kajiro M, Komatsu Y, Fujimura A, et al:
Estrogen inhibits transforming growth factor beta signaling by
promoting Smad2/3 degradation. J Biol Chem. 285:14747–14755. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Noyola-Martinez N, Halhali A and Barrera
D: Steroid hormones and pregnancy. Gynecol Endocrinol. 35:376–384.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Xu B, Wang W, Zhai X and Chen X:
Efficacy and safety of fulvestrant in postmenopausal patients with
hormone receptor-positive advanced breast cancer: A systematic
literature review and meta-analysis. Breast Cancer Res Treat.
171:533–544. 2018. View Article : Google Scholar
|
|
32
|
Gao J, Deng F and Jia W: Inhibition of
indoleamine 2,3-dioxy-genase enhances the therapeutic efficacy of
immunogenic chemotherapeutics in breast cancer. J Breast Cancer.
22:196–209. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nishi M, Yoshikawa K, Higashijima J,
Tokunaga T, Kashihara H, Takasu C, Ishikawa D, Wada Y and Shimada
M: The impact of indoleamine 2,3-dioxygenase (IDO) expression on
Stage III gastric cancer. Anticancer Res. 38:3387–3392. 2018.
View Article : Google Scholar : PubMed/NCBI
|
